Artículos del autor

solaci

Antiplatelet

Xience Receives CE Mark for Short and Ultrashort DAPT Schemes

Dual antiplatelet therapy (DAPT) one month after angioplasty with Xience stent was approved in Europe for patients...
solaci -
Antiplatelet

Dual Antiplatelet Therapy and TAVR: Obsolete Guidelines

The current guidelines recommend dual antiplatelet therapy (DAPT) 3 to 6 months after transcatheter aortic valve replacement...
solaci -
Chronic Ischemic cardiopathy

CT and Angiography Agreement in Patients from the ISCHEMIA Trial

Computed tomographic (CT) angiography showed a high degree of agreement with conventional angiography to detect significant coronary...
solaci -
Institutional News

29/04 | Webinar SOLACI – TAVI TALKS: Why Hemodynamics Really Matters

solaci -
Coronary disease

05/01 | MIL Group / SOLACI / CACI Webinar: Strategies to Improve the Training of Latin American Interventionist Women

We invite you to participate in a new SOLACI virtual event open to the entire community. It...
solaci -
Chronic Ischemic cardiopathy

IVUS vs OCT to Guide PCI: Which Should We Choose?

Controlling stent expansion with optical coherence tomography (OCT) based on an external elastic membrane–based protocol for stent...
solaci -
Structural heart disease

Cerebral Protection Devices during TAVR in the Daily Practice

The theory behind the use of cerebral protection devices during TAVR is good, but hard to test....
solaci -
Scientific Articles COVID-19

Thrombocytopenia and Thrombosis May Be Linked to AstraZeneca Vaccine, Analysis Reports

This is one of the first papers documenting rare thrombotic effects related to the ChAdOx1 nCoV-19 vaccine...
solaci -